Better cardiac diagnosis and fewer hospitalizations are the promise with newly FDA-cleared CardiArc, a SPECT imaging device that will give physicians sharper images of blood flow and function of their patients hearts — in half the time previously required.
Offered by CardiArc Ltd., the patented, smaller and faster technology for cardiac single photon emission computed tomography (SPECT) has twice the resolution of existing devices. The system is as small as an executive chair, runs on 110 Volts AC and fits easily in a 6 by 7 foot exam room without remodeling.